FORD ALFRED J JR (Chief Commercial Officer) sold 20.7% of their position (27.63K shares) of KESTRA MEDICAL TECHNOLOGIES, LTD. on the open market
Open‑market sale worth $642.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/3/2026ACC: 0001193125-26-331065
Officer· Chief Commercial Officer
Since Mar 2025
-27.63K
Net shares
Net seller
$642.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
27.63K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
−5.94K
Price / share
$22.76
Trade value
$135.12K
% of position
4.4%
7/30/2026
133.47K→127.53K
Common Shares
Direct
Shares
−8.68K
Price / share
$22.61
Trade value
$196.28K
% of position
6.8%
7/31/2026
127.53K→118.85K
Common Shares
Direct
Shares
−13.02K
Price / share
$23.90
Trade value
$311.12K
% of position
11.0%
8/3/2026
118.85K→105.84K
Total
Net shares
−27.63K
Net value
-$642.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 7/30/2026 | S · Sale | −5.94K | $22.76 | $135.12K | 4.4% | 133.47K | 127.53K |
| Common Shares Direct | 7/31/2026 | S · Sale | −8.68K | $22.61 | $196.28K | 6.8% | 127.53K | 118.85K |
| Common Shares Direct | 8/3/2026 | S · Sale | −13.02K | $23.90 | $311.12K | 11.0% | 118.85K | 105.84K |
| Total | −27.63K | -$642.52K | ||||||
Derivative Transactions0
No derivative transactions reported